{"id":"serum-antiscorpion","safety":{"commonSideEffects":[{"rate":null,"effect":"Serum sickness"},{"rate":null,"effect":"Hypersensitivity reaction"},{"rate":null,"effect":"Anaphylaxis"}]},"_chembl":{"chemblId":"CHEMBL2109149","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This biologic product contains immunoglobulins (antibodies) derived from animal serum that have been raised against scorpion venom antigens. Upon administration, these antibodies bind to and neutralize active venom components, preventing their pathophysiological effects on the nervous and cardiovascular systems. It is used as an acute treatment to counteract systemic envenomation.","oneSentence":"Serum antiscorpion is a polyclonal antivenom that neutralizes scorpion venom toxins through specific antibody binding.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:07:31.853Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Scorpion envenomation (systemic toxicity)"}]},"trialDetails":[{"nctId":"NCT00739440","phase":"PHASE4","title":"Randomized Controlled Trial to Compare Two Anti-scorpion Serums","status":"COMPLETED","sponsor":"Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.","startDate":"2008-08","conditions":"Scorpion Sting","enrollment":120},{"nctId":"NCT01415830","phase":"PHASE3","title":"Compare Two Anti-Scorpion Venom Serum In Children","status":"COMPLETED","sponsor":"Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.","startDate":"2011-08","conditions":"Scorpion Sting","enrollment":120},{"nctId":"NCT00753064","phase":"PHASE3","title":"AScVS and/ or Prazosin for Scorpion Envenomation","status":"COMPLETED","sponsor":"Haffkine Bio-Pharmaceutical Corporation Ltd.","startDate":"2006-09","conditions":"Scorpion Envenomation","enrollment":81}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":25,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["anti-Scorpion venom Serum"],"phase":"marketed","status":"active","brandName":"serum antiscorpion","genericName":"serum antiscorpion","companyName":"Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.","companyId":"laboratorios-de-biologicos-y-reactivos-de-m-xico-s-a-de-c-v","modality":"Biologic","firstApprovalDate":"","aiSummary":"Serum antiscorpion is a protein-based intervention used to treat scorpion sting and scorpion envenomation, as indicated by ClinicalTrials.gov. It is a polyvalent antiscorpion serum, as shown in the randomized controlled trial \"Randomized Controlled Trial to Evaluate Efficiency and Safety of the Polyvalent Antiscorpion Serum of Birme\" (NCT00739440).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}